EUROSIDA PUBLICATIONS 2024
 
  1.  
 

IN PRESS

 
  1. Association between change in body mass index and risk of hypertension and dyslipidemia in people receiving integrase inhibitors and/or tenofovir alafenamide compared to other contemporary antiretroviral regimens: Byonanebye DM, Polizzotto MN, Maltez F, Rauch A, Pfistershammer KG, Wit F, De Wit S, Castagna A, Monforte AD, Mussini C, Wasmuth JC, Fontas E, Abela I, Sarcletti M, Matharu LB, Jaschinski N, Peters N, Hosein SR, Vannappagari V, Cohen C, Bissio E, Mocroft A, Law M, Ryom L, Petoumenos L. The RESPOND consortium of prospective cohorts. Published in Lancet HIV
  2. Differences in integrated assessment and management of non-communicable diseases (NCDs) for People with HIV across the WHO European Region
    HIV Medicine 2024
  3. Prevalence and outcomes of severe SARS-CoV-2 infection among people living with HIV Europe in the large multicenter EuroSIDA study
    HIV Medicine 2024